DarioHealth Corp.
DRIO
$6.28
$0.223.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.75% | 4.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.75% | 4.47% | |||
| Cost of Revenue | -1.74% | 24.02% | |||
| Gross Profit | 13.13% | -6.60% | |||
| SG&A Expenses | -6.96% | -4.79% | |||
| Depreciation & Amortization | -2.21% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.53% | -4.82% | |||
| Operating Income | 14.63% | 9.72% | |||
| Income Before Tax | 8.45% | 14.50% | |||
| Income Tax Expenses | -31.33% | -- | |||
| Earnings from Continuing Operations | 8.66% | 13.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.66% | 13.71% | |||
| EBIT | 14.63% | 9.72% | |||
| EBITDA | 15.48% | 10.18% | |||
| EPS Basic | 38.45% | 31.13% | |||
| Normalized Basic EPS | -10.01% | 66.08% | |||
| EPS Diluted | 38.45% | 31.13% | |||
| Normalized Diluted EPS | -10.01% | 66.08% | |||
| Average Basic Shares Outstanding | -16.79% | 152.08% | |||
| Average Diluted Shares Outstanding | -16.79% | 152.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||